Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

Big Lots is struggling! We delve into the factors behind store closures and layoffs, exploring the impact of inflation and ...

The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...

Trump administration officials have defended the mass dismissals, saying they are overdue and necessary to make the ...

WASHINGTON (AP) — The number of Americans filing for unemployment benefits fell last week to the lowest level in three months ...

WASHINGTON (AP) — One of the nation’s oldest civil rights organizations on Thursday declared a “state of emergency” for ...

Consumers picked up their spending in June showing resilience despite anxiety high over tariffs and the U.S. economy.

The company will pause several gene therapy development programs, for which it intends to seek partners and other strategic alternatives.

Sarepta's cost-saving moves, FDA surprises, and pipeline potential position SRPT as a unique opportunity. Read here for an ...

Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment, Sarepta ...

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection ...